Cancer care and COVID-19 in Seattle, the first U.S. epicenter
How is oncology adapting to COVID-19?
Disruptions in cancer care in the era of COVID-19
New melanoma treatments linked to mortality decline
Melanoma incidence in the U.S. has continued to rise, but BRAF inhibitors and immune checkpoint inhibitors are extending survival, data suggest....
Patients accept artificial intelligence in skin cancer screening
Although patient and clinician artificial intelligence tools were acceptable to most patients surveyed, 94% emphasized the importance of a human...
Lenvatinib/pembrolizumab has good activity in advanced RCC, other solid tumors
Two-thirds of patients with advanced renal cell carcinoma had a clinical response to the TKI/immune checkpoint inhibitor combination.
Sharp declines for lung cancer, melanoma deaths fuel record drop in cancer mortality
Reductions in smoking are largely responsible for the lung cancer progress, while immunotherapy and targeted treatments have improved survival in...
In Oregon, ‘war on melanoma’ takes flight
LAS VEGAS – Research project hopes to shrink melanoma mortality by emphasizing education, screening.
Melanoma incidence continues to increase, yet mortality stabilizing
LAS VEGAS –Targeted screening efforts that stratify by risk factors and by age “makes screening more efficient and more cost effective.”
Levothyroxine dose for checkpoint inhibitor toxicity may be too high
CHICAGO – Dosing need not be automatically boosted when starting checkpoint inhibitor therapy.